|
|
Volumn 40, Issue 4, 2001, Pages 415-421
|
|
Evaluation of the clinical value of urinary NMP22 as a marker in the screening and surveillance of transitional cell carcinoma of the urinary bladder
a
|
|
Author keywords
NMP22; Transitional cell carcinoma; Tumour marker; Urinary bladder
|
|
Indexed keywords
PROTEIN;
TUMOR MARKER;
ARTICLE;
BLADDER CARCINOMA;
CANCER EPIDEMIOLOGY;
CANCER SCREENING;
CANCER STAGING;
CLINICAL FEATURE;
CONTROLLED STUDY;
CYSTOSCOPY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
FEMALE;
FOLLOW UP;
HEMATURIA;
HUMAN;
KIDNEY PAPILLA;
MAJOR CLINICAL STUDY;
MALE;
MICROSCOPY;
PREDICTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PROTEIN URINE LEVEL;
TRANSITIONAL CELL CARCINOMA;
TUMOR VOLUME;
URINALYSIS;
URINE CYTOLOGY;
CARCINOMA, TRANSITIONAL CELL;
CYSTOSCOPY;
HEMATURIA;
HUMANS;
NUCLEAR PROTEINS;
PROSPECTIVE STUDIES;
SENSITIVITY AND SPECIFICITY;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
URINE;
|
|
EID: 0035671757
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000049809 Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|
